Long-Acting Injectable (LAI) - Atypical Antipsychotics ...
1.2K
Description

Long-Acting Injectable (LAI) - Atypical Antipsychotics 

INVEGA TRINZA 3 MONTHS 

ARISTADA 2 MONTHS 

INVEGA 1 MONTH

SUSTENNA 1 MONTH

ABILIFY 1 MONTH

MAINTENA 1 MONTH

ZYPREXA 1 MONTH

RELPREVV 1 MONTH

RISPERDAL 2 WEEKS

CONSTA 2 WEEKS

 

Here's the full list of available atypical antipsychotics available in Long-Acting Injectable formulations. These atypical antipsychotics, otherwise known as second-generation antipsychotics, are used in the treatment of schizophrenia. Adherence to daily medications can be tough for any patient, but having uncontrolled schizophrenia can make adherence even harder, which is why these LAI's can be so helpful for some patients. Risperdal Consta is the shortest lasting which requires dosing every 2 weeks, compared to Invega Trinza which only requires dosing every 3 months (that's only 4 injections per year!). Pharmacists are able to administer these injections to patients, too!



Jarred Prudencio, PharmD - https://www.instagram.com/ambcarerx



#LongActing #Injectable #LAI #Atypical #Antipsychotics #Pharmacology #Duration #Psychiatry
Contributed by

Dr. Gerald Diaz
@GeraldMD
Board Certified Internal Medicine Hospitalist, GrepMed Editor in Chief πŸ‡΅πŸ‡­ πŸ‡ΊπŸ‡Έ - Sign up for an account to like, bookmark and upload images to contribute to our community platform. Follow us on IG:  https://www.instagram.com/grepmed/ | Twitter: https://twitter.com/grepmeded/
0 Comments

Related content